Pharmaceutical Intelligence Network Drug intelligence data Pharmaceutical intelligence medical equipment data PatentPass Drug intelligence consultation Medicine Wisdom Collection Yaozhitong CRO Medicine Wisdom Lecture Hall Forum exchange Elite Collection Medicine Wisdom Search Industrial brain
Sign in register
Mobile terminal
Official account of Yaozhi.com
Yaozhi News H5
Hot News
Daily list Weekly list
Recommended topics
more
Featured this week
Original recommendation
Original recommendation
AI Pharmaceutical was born first! Jingtai Technology was successfully listed
AI Pharmaceutical was born first! Jingtai Technology was successfully listed
Medicinal tyrant
Medicinal tyrant
New Drugs | May: A number of new lung cancer drugs around the world were approved for marketing, and Hispec's new class 1 neuralgia treatment drugs were approved in China
New Drugs | May: A number of new lung cancer drugs around the world were approved for marketing, and Hispec's new class 1 neuralgia treatment drugs were approved in China
Record of Good Medicine
Record of Good Medicine
Top 100 best-selling drugs in the world
Top 100 best-selling drugs in the world
more
Yaozhi Video
more
tabloid
more
Yaozhi New Media
Yaozhi Headline Public Account
The subscription account of Yaozhi News under Yaozhi Net, which launched industry news and in-depth hot spot analysis; Authoritative policy interpretation and cutting-edge technology analysis; Unique expert opinions and stories of leading figures; Make precise investment decisions and jointly create industrial ecology.
Yaozhi Headline Video Number
The Yaozhi News video number of Yaozhi. com includes video reports of industry hot news, live broadcast of industry high-level conferences, online sharing of dry goods lectures, etc., and transmits the "new voice" of the industry with the Yaozhi Talk column.
Medicine Wisdom Elite Collection
It is a leading pharmaceutical online learning platform in China, focusing on key industry news, online/offline academic conferences, dry goods learning materials, covering the whole pharmaceutical industry chain disciplines such as production, learning, research, use, and marketing.
Agenda confirmed! The 9th PDI Summit in 2024
(Jointly with CPHI) The Second High end Seminar on the Development Frontier and Practice of Small Molecular Innovative Drugs
Chinese listed equipment
Deep experience of Pharmaceutical Intelligence Data Enterprise Edition
Thursday, June 13
Medicine Wisdom Headlines
AI Pharmaceutical was born first! Jingtai Technology was successfully listed
Jingtai Technology , AI Pharmaceutical , it's sunny
2024-06-13
When can CXO pass the "ten thousand mountains"
CXO , Biosafety Act
2024-06-13
The first Class 1 innovative drug in Tibet was launched
Class 1 innovative drugs , Clegabalin Benzenesulfonate
2024-06-12
T-DXd side effects solved?
2024 ASCO , AstraZeneca , Oshtini
2024-06-11
newest Purchase in quantity traditional Chinese medicine Chemical medicine Biological medicine Innovative medicine Medical insurance catalogue Consistency evaluation Vaccine R&D COVID-19 epidemic Drug Discovery
Just now! In 2024, the official announcement of the adjustment of the national medical insurance catalogue will be launched

Just now! In 2024, the official announcement of the adjustment of the national medical insurance catalogue will be launched

Renewal and bidding follow the rules of last year

Adjustment of national medical insurance catalogue , Draft for Comments 11 hours ago
AI Pharmaceutical was born first! Jingtai Technology was successfully listed
Original recommendation
Original recommendation

AI Pharmaceutical was born first! Jingtai Technology was successfully listed

It is also the first share of Hong Kong's special technology

Jingtai Technology , AI Pharmaceutical , it's sunny 13 hours ago
The 9th "Maker China" Sichuan SME Innovation and Entrepreneurship Competition "Medical Health" Special Preliminaries

The 9th "Maker China" Sichuan SME Innovation and Entrepreneurship Competition "Medical Health" Special Preliminaries

"Looking for innovative wave breakers"

Medical health , Maker China , Pharmaceutical innovation 14 hours ago
Cornerstone Pharmaceutical Announces Taijihua ® The application for marketing registration of drugs (avatinib tablets) transferred from overseas to domestic production has been approved by the State Drug Administration of China
Hot
Hot

Cornerstone Pharmaceutical Announces Taijihua ® The application for marketing registration of drugs (avatinib tablets) transferred from overseas to domestic production has been approved by the State Drug Administration of China

Tejiva has demonstrated excellent efficacy in several clinical trials

Cornerstone Pharmaceutical , Avastinib Tablets 15 hours ago
Renji Science Popularization | When talking about fear of thrombosis, there is a good way to prevent it!

Renji Science Popularization | When talking about fear of thrombosis, there is a good way to prevent it!

How to prevent thrombus?

thrombus , hypertension , diabetes 15 hours ago

The first in the world! Lilly's "glucagon nasal powder" was approved for listing in China

The first in the world! Lilly's "glucagon nasal powder" was approved for listing in China
The first in the world! Lilly's "glucagon nasal powder" was approved for listing in China
The first in the world! Lilly's "glucagon nasal powder" was approved for listing in China
Lilly Pharmaceutical , diabetes 19 hours ago
Renji Science Popularization | Unlock the secret of fingers: the truth of snapping fingers and the way to prevent

Renji Science Popularization | Unlock the secret of fingers: the truth of snapping fingers and the way to prevent

You may be experiencing the trouble of "snapping your fingers".

Stenosing tenosynovitis of flexor tendon 15 hours ago
Renji Science Popularization | Do you know the little knowledge about atrial fibrillation

Renji Science Popularization | Do you know the little knowledge about atrial fibrillation

What are the risk factors for atrial fibrillation?

Paroxysmal atrial fibrillation , persistent atrial fibrillation , Permanent atrial fibrillation 18 hours ago
Novartis Group's "Lucotinib Phosphate Tablets" has been approved as a new indication for the treatment of chronic graft-versus-host disease in China

Novartis Group's "Lucotinib Phosphate Tablets" has been approved as a new indication for the treatment of chronic graft-versus-host disease in China

The treatment of cGVHD is facing challenges and needs to seek new solutions.

Novartis AG , Rucotinib Phosphate Tablets 18 hours ago
When can CXO pass the "ten thousand mountains"
Original recommendation
Original recommendation

When can CXO pass the "ten thousand mountains"

Turning around, domestic CXO enterprises rushed to the European market.

CXO , Biosafety Act 19 hours ago

Baekje Shenzhou "Anti tumor Class 1 New Drug" approved for clinical use

Baekje Shenzhou "Anti tumor Class 1 New Drug" approved for clinical use
Baekje Shenzhou "Anti tumor Class 1 New Drug" approved for clinical use
Baekje Shenzhou "Anti tumor Class 1 New Drug" approved for clinical use
Baekje China , antineoplastic drugs 2024-06-12
Hengrui Pharmaceutical's research on the treatment of colorectal cancer with "Carrelizumab" and "Apatinib" was published in The Lancet Oncology

Hengrui Pharmaceutical's research on the treatment of colorectal cancer with "Carrelizumab" and "Apatinib" was published in The Lancet Oncology

"Double Ai" combination shows its power again.

Hengrui Pharmaceutical , Colorectal cancer 19 hours ago
True · Open up, Huada Wisdom Makes Amazing Weapons

True · Open up, Huada Wisdom Makes Amazing Weapons

A good business that can make a steady profit without loss

Huada Zhizao ,NGS , nanopore 19 hours ago
Cinda Biology "IBI343" was accredited as a fast track by FDA

Cinda Biology "IBI343" was accredited as a fast track by FDA

Treatment of advanced pancreatic cancer.

IBI343 , Xinda Biology 19 hours ago
Exclusive | After CXO, the wave "breaks the dimensional wall" and opens up the second battlefield
recommend
recommend

Exclusive | After CXO, the wave "breaks the dimensional wall" and opens up the second battlefield

Just need: cross IVD, vaccine and CGT industries

COVID-19 epidemic , Innovative medicine , Bai'ao Biology 19 hours ago
Microinvasive Medical redeemed $700 million of convertible bonds; Jindik cut the price of four valent influenza vaccine products
recommend
recommend

Microinvasive Medical redeemed $700 million of convertible bonds; Jindik cut the price of four valent influenza vaccine products

Dynamics of medicine and equipment

Kaituo Biology , Lilly 19 hours ago
Special audit started! Thoroughly check hospital accounts
Hot
Hot

Special audit started! Thoroughly check hospital accounts

Auditors enter the hospital and strictly check the purchase of consumables and equipment

drugs , Consumables , equipment procurement 19 hours ago
EHA observation | CAR-T new trend from China's oral report
recommend
recommend

EHA observation | CAR-T new trend from China's oral report

The rear line is more backward and the front line is more forward

CAR-T therapy , Innovative medicine Keji Pharmaceutical 19 hours ago
Can 40 million US dollars solve the litigation crisis of Gilead's HIV drug relapse

Can 40 million US dollars solve the litigation crisis of Gilead's HIV drug relapse

Propose a US $40 million settlement plan to settle the claims of more than 2000 plaintiffs

Gilead , AIDS , HIV infection 20 hours ago
Where will Hengrui Medicine go next?
Hot
Hot

Where will Hengrui Medicine go next?

Can "Shuangai" land at sea?

Hengrui Pharmaceutical , generic ,PD-1 20 hours ago
Load more
more
Key exhibitions
more
Columnist
more
Medicine Wisdom Headlines
Authoritative policy interpretation, cutting-edge technology analysis, unique expert views, and stories of leading figures!
Pharmaceutical Intelligence Network
Gather medical policies and regulations, industry information, hot news, data analysis, etc., break through the medical information barrier, and build the best bridge between production, learning, and research.
Pharmaceutical intelligence medical equipment data
Global medical device big data solution service provider
Traditional Chinese medicine
We are committed to becoming the most open, innovative and reliable pharmaceutical service platform in the world, so that good drugs can benefit the public earlier.
Enterprise announcement
The enterprise is changing, and the dynamic authoritative announcements are all available.
Reader's voice

Cinda Bio's "Pemetenib Tablets" was approved for listing in Macao, China

fierce

Ranked 8th, setting a new high for Chinese pharmaceutical enterprises! Hengrui Pharmaceutical has been selected into the top 25 pipeline scale of global pharmaceutical companies for three consecutive years

sure

In March, the global new drug research and development progress report was released! Complete list attached

fabulous

It's time to imitate domestic innovative medicine

There are no four imitations of bicyclic alcohol

GLP-1 has become the "hope" of many Chinese pharmaceutical enterprises

It's too voluminous. Few can survive

Newly launched, Fuhong Hanlin H drug was approved for marketing in Indonesia

Experience harm!

Smeaglutide, the "last cloud" on the head has cleared

As the world's first oral polypeptide antidiabetic drug, this breakthrough in drug design and research!

The results of the third phase clinical study of cindatoximab were published in the journal of JACC

fierce

More than 500 drugs are under research worldwide. How to overcome the technical difficulties in non clinical research of ADC drugs?

Can I write another article about the specific content

For the first time in China! Centralized purchase of Chinese patent medicine sounded the "outpost", including 3 billion "super large varieties"

Is centralized purchase going to start again

Copyright Reserved @ 2009-2024 YAOZH COM MIIT Filing No.: YCPB 10200070-3

Customer service hotline: 400-678-0778 Complaints and suggestions: 023-62988285 to 802 E-mail: admin@yaozh.com

Internet value-added telecommunications business license No.: Chongqing B2-20120028 Internet drug information service qualification certificate: (Chongqing) - profit-making - 2021-0017

Yaozhi's website: Pharmaceutical Intelligence Network | Yaozhi News | Medicine Wisdom Lecture Hall | Yaozhi Media | Pharmaceutical Intelligence Forum | Drug intelligence data | Company qualification | contact us

scan

QR-code

Copyright © 2009-2024 YAOZH COM All Rights Reserved. MIIT Filing No.: YCPB 10200070-3

YGGANB No. 50010802001068

Complaint hotline: (023) 6262 8397

Email: tousu@yaozh.com

QQ: 236960938